Evidence map›Paper›PMID 25114118›Full record

ArticleInfection and immunity2014

Polymorphonuclear leukocytes restrict growth of Pseudomonas aeruginosa in the lungs of cystic fibrosis patients.

Kasper N Kragh, Morten Alhede, Peter Ø Jensen, Claus Moser, Thomas Scheike, Carsten S Jacobsen, Steen Seier Poulsen, Steffen Robert Eickhardt-Sørensen, Hannah Trøstrup, Lars Christoffersen and 5 more

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04803695 (Role of Pseudomonas Aeruginosa Biofilms in Exacerbations in Patients With Bronchiectasis With and Without Chronic Obstructive Pulmonary Disease), which is not on this map. Cited by 92 papers.

0numbers the graph read from it
0cells of the map it votes in
92citing papers in PubMed
11.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04803695 unknown statusnot on this mapstarted 2018, after this paper: background citation

Role of Pseudomonas Aeruginosa Biofilms in Exacerbations in Patients With Bronchiectasis With and Without Chronic Obstructive Pulmonary Disease

TypeobservationalSponsorHospital Clinic of BarcelonaRan2018 to 2021Enrolled96ConditionsBronchiectasis, Microbial Colonization, Pseudomonas Aeruginosa, BiofilmArmsMicrobial biofilm diagnose
3 · Its place in the literature

Who cites it

92 citing papers in PubMed, 151 citations in OpenAlex.

  1. Trial
  2. mSystems · 2026
    Article
  3. Hijacking anaerobic metabolism to restore antibiotic efficacy inApplied and environmental microbiology · 2025
    Article
  4. Microorganisms · 2024
    Review
  5. Recreating chronic respiratory infectionsEuropean respiratory review : an official journal of the European Respiratory Society · 2024
    Review
  6. Targeting Anaerobic Respiration inAdvances in wound care · 2024
    Article
  7. Article
  8. Article
  9. The non-attached biofilm aggregate.Communications biology · 2023
    Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

32 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 3 countries.

Kasper N KraghDepartment of International Health, Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
Morten AlhedeDepartment of International Health, Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark Department of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark.
Peter Ø JensenDepartment of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark.
Claus MoserDepartment of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark.
Thomas ScheikeDepartment of Public Health, Section of Biostatistics, University of Copenhagen, Copenhagen, Denmark.
Carsten S JacobsenGeological Survey of Denmark and Greenland, Copenhagen, Denmark.
Steen Seier PoulsenDepartment of Biomedical Science, University of Copenhagen, Copenhagen, Denmark.
Steffen Robert Eickhardt-SørensenDepartment of International Health, Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
Hannah TrøstrupDepartment of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark.
Lars ChristoffersenDepartment of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark.
Hans-Petter HougenDepartment of Forensic Medicine, University of Copenhagen, Copenhagen, Denmark.
Lars F RickeltMarine Biological Section, Department of Biology, University of Copenhagen, Helsingør, Denmark.
Michael KühlMarine Biological Section, Department of Biology, University of Copenhagen, Helsingør, Denmark Plant Functional Biology and Climate Change Cluster, University of Technology Sydney, New South Wales, Sydney, Australia Singapore Centre on Environmental Life Science Engineering, School of Biological Science, Nanyang Technological University, Singapore.
Niels HøibyDepartment of International Health, Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark Department of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark.
Thomas BjarnsholtDepartment of International Health, Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark Department of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark tbjarnsholt@sund.ku.dk.
University of Copenhagen · DKRigshospitalet · DKGeological Survey of Denmark and Greenland · DKNanyang Technological University · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cystic fibrosis (CF) patients have increased susceptibility to chronic lung infections by Pseudomonas aeruginosa, but the ecophysiology within the CF lung during infections is poorly understood. The aim of this study was to elucidate the in vivo growth physiology of P. aeruginosa within lungs of chronically infected CF patients. A novel, quantitative peptide nucleic acid (PNA) fluorescence in situ hybridization (PNA-FISH)-based method was used to estimate the in vivo growth rates of P. aeruginosa directly in lung tissue samples from CF patients and the growth rates of P. aeruginosa in infected lungs in a mouse model. The growth rate of P. aeruginosa within CF lungs did not correlate with the dimensions of bacterial aggregates but showed an inverse correlation to the concentration of polymorphonuclear leukocytes (PMNs) surrounding the bacteria. A growth-limiting effect on P. aeruginosa by PMNs was also observed in vitro, where this limitation was alleviated in the presence of the alternative electron acceptor nitrate. The finding that P. aeruginosa growth patterns correlate with the number of surrounding PMNs points to a bacteriostatic effect by PMNs via their strong O2 consumption, which slows the growth of P. aeruginosa in infected CF lungs. In support of this, the growth of P. aeruginosa was significantly higher in the respiratory airways than in the conducting airways of mice. These results indicate a complex host-pathogen interaction in chronic P. aeruginosa infection of the CF lung whereby PMNs slow the growth of the bacteria and render them less susceptible to antibiotic treatment while enabling them to persist by anaerobic respiration.

Indexed as

AdultAnimalsBiofilmsCystic FibrosisFemaleHumansIn Situ Hybridization, FluorescenceLung DiseasesMaleMiceMice, Inbred BALB CNeutrophilsPeptide Nucleic AcidsPseudomonas aeruginosaPseudomonas InfectionsPeptide Nucleic Acids

Identifiers

PMID25114118
PMCPMC4249348
OpenAlexW2128057907

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.